Clinical: Journal Reflection
Start Assignment
Reflective Journal Instructions
You will create 7 entries for your Reflective Journal about a patient encounter. In the 7th entry, you will review the previous 6 entries and evaluate your progress in reflective practice over the course of the term. Each journal should be a minimum of 250 words. (Reflective Clinical Journal on the Role of PMHNP provider)
The purpose of this reflective journal is self-reflection regarding the role in the process of self-reflection as a PMHNP provider. Through reflective practice, the student will evaluate their own emotional health and recognize one’s own feelings as well as one’s ability to monitor and manage those feelings. The point of the exercise is to learn yourself, your triggers, the types of cases you end up getting overly involved with, and those you’d rather refer to someone else. The idea is to be able to personally reflect on your behaviors/thoughts/decisions and how those impact you in the role of PMHNP. (Reflective Clinical Journal on the Role of PMHNP provider)
Address the following items:
- Compare and contrast methadone and buprenorphine. Include mechanism of action, and pros/cons.
- Do you plan or have a desire to work with substance use disorders in an in-depth fashion.
Use the appropriate APA formatting with a minimum of 2 references to support your work.
All components must be discussed to receive full credit as complete.
Note: Grades of Incomplete on this assignment will result in a clinical failure.
Rubric
NU675 Unit 8 Assignment – Clinical: Journal Reflection
NU675 Unit 8 Assignment – Clinical: Journal Reflection
CriteriaRatingsPts
This criterion is linked to a Learning OutcomeContent Reflection
8 pts
Level 5
Reflection demonstrates a high degree of critical thinking in applying, analyzing, and evaluating key course concepts and theories from readings, lectures, media, discussions activities, and/or assignments. Insightful and relevant connections made through contextual explanations, inferences, and examples.(Reflective Clinical Journal on the Role of PMHNP provider)
5.6 pts
Level 3
Reflection demonstrates some degree of critical thinking in applying, analyzing, and/or evaluating key course concepts and theories from readings, lectures, media, discussions activities, and/or assignments. Connections made through explanations, inferences, and/or examples.(Reflective Clinical Journal on the Role of PMHNP provider)
3.2 pts
Level 1
Reflection demonstrates limited critical thinking in applying, analyzing, and/or evaluating key course concepts and theories from readings, lectures, media, discussions, activities, and/or assignments Minimal connections made through explanations, inferences, and/or examples.(Reflective Clinical Journal on the Role of PMHNP provider)
0 pts
Level 0
Reflection lacks critical thinking. Superficial connections are made with key course concepts and course materials, activities, and/or assignments.(Reflective Clinical Journal on the Role of PMHNP provider)
8 pts
This criterion is linked to a Learning OutcomePersonal Growth
8 pts
Level 5
Conveys strong evidence of reflection on own work with a personal response to the self-assessment questions posed. Demonstrates significant personal growth and awareness of deeper meaning through inferences made, examples, well developed insights, and substantial depth in perceptions and challenges. Synthesizes current experience into future implications.(Reflective Clinical Journal on the Role of PMHNP provider)
5.6 pts
Level 3
Conveys evidence of reflection on own work with a personal response to the self-assessment questions posed. Demonstrates satisfactory personal growth and awareness through some inferences made, examples, insights, and challenges. Some thought of the future implications of current experience.(Reflective Clinical Journal on the Role of PMHNP provider)
3.2 pts
Level 1
Conveys limited evidence of reflection on own work in response to the self-assessment questions posed. Demonstrates less than adequate personal growth and awareness through few or simplistic inferences made, examples, insights, and/or challenges that are not well developed. Minimal thought of the future implications of current experience.(Reflective Clinical Journal on the Role of PMHNP provider)
0 pts
Level 0
Conveys inadequate evidence of reflection on own work in response to the self-assessment questions posed. Personal growth and awareness are not evident and/or demonstrates a neutral experience with negligible personal impact. Lacks enough inferences, examples, personal insights and challenges, and/or future implications are overlooked.(Reflective Clinical Journal on the Role of PMHNP provider)
8 pts
This criterion is linked to a Learning OutcomeTimliness
4 pts
Level 5
Journal reflection is submitted on or before deadline.
2.8 pts
Level 3
Journal reflection is submitted within 1 day (24 hours) after the deadline.
1.6 pts
Leve 1
Journal reflection is submitted 1-2 days (25-48 hours) after the deadline.
0 pts
Level 0
Journal reflection is submitted 2-3 days (49-72 hours) after the deadline.
4 pts
Total Points: 20
Reflective Clinical Journal on the Role of PMHNP provider-Solution
Opioids are synthetic derivatives of opiates, including methadone and buprenorphine. Since methadone is a full opioid agonist, overdose-related deaths, typically caused by respiratory depression, are a life-threatening issue. In recent years, the partial opioid agonist buprenorphine has grown in popularity as a treatment option in therapeutic settings. Buprenorphine has been hailed as a new dawn for treating heroin addiction due to its distinct pharmacological mode of action, with indications of a lower risk of addiction and overdose (Whelan & Remski, 2017). The central nervous system contains a variety of opioid receptor subtypes, and their activation has varying effects. Both buprenorphine and methadone produce analgesia and euphoria because their interaction with mμ and delta receptor subtypes influence adenyl cyclase activity and activate inwardly rectifying potassium channels, which releases endogenous opioids like endorphins and enkephalins, but each to different levels. Buprenorphine has several pros over methadone for usage as an opioid replacement therapy because of its distinct pharmacologic profile (Whelan & Remski, 2017). It has little intrinsic action at mμ receptors, for instance. Buprenorphine is, therefore, less effective than a complete mμ agonist, such as methadone, and produces less analgesia and euphoria, but it still reduces withdrawal symptoms.(Reflective Clinical Journal on the Role of PMHNP provider)
Substance use disorders are associated with severe health, social function, and voluntary control impairment. Therefore, I would like to work with substance use disorders comprehensively to help improve patients’ quality of life. I desire to help people live optimal life through clinical practice. Substance use disorders are growing. The CDC data shows that 13% of Americans use substances to cope with stress or emotions, especially during COVID-19 (Abramson, 2021). Substance use disorders are a public health problem, and I would like to be part of the solution, hence the need to work with substance use disorders in an in-depth fashion.(Reflective Clinical Journal on the Role of PMHNP provider)
References
Abramson, A. (2021, March 1). Substance use during the pandemic. American Psychology Association. https://www.apa.org/monitor/2021/03/substance-use-pandemic/
Whelan, P. J., & Remski, K. (2017). Buprenorphine vs. methadone treatment: A review of evidence in both developed and developing worlds. Journal of neurosciences in rural practice, 3(1), 45–50. https://doi.org/10.4103/0976-3147.91934
Write From Scratch